The Androgen Receptor and Its Crosstalk With the Src Kinase During Castrate-Resistant Prostate Cancer Progression

While the androgen receptor (AR) signalling is the mainstay therapeutic target for metastatic prostate cancers, these tumours will inevitably develop therapy resistance to AR pathway inhibitors suggesting that prostate tumour cells possess the capability to develop mechanisms to bypass their depende...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Lin, Han, Bo, Dong, Xuesen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271573/
https://www.ncbi.nlm.nih.gov/pubmed/35832549
http://dx.doi.org/10.3389/fonc.2022.905398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271573/
https://www.ncbi.nlm.nih.gov/pubmed/35832549
http://dx.doi.org/10.3389/fonc.2022.905398

Ejemplares similares